Wall Street Sees Downside for Kraft Heinz and Schneider, but Eli Lilly Could Defy Expectations

Analyst
โดย Yahoo Finance·Read original
Summary · why it matters

Wall Street analysts have set bearish price targets for Kraft Heinz and Schneider, implying potential declines of 5.8% and 7.2% respectively, while Eli Lilly’s consensus target suggests a nearly flat return. Kraft Heinz faces shrinking unit sales and a projected 2.2% revenue drop over the next year, with its operating margin plunging 25.1 percentage points. Schneider has posted unexciting sales growth and a 14.9% annual decline in earnings per share over five years, alongside shrinking returns on capital. In contrast, Eli Lilly delivered 41.8% annual revenue growth over two years and expanded its adjusted operating margin by 22.9 percentage points, with share repurchases boosting earnings per share growth to 29.6% annually over five years.

Impact on stocks 3

Consumer Staples▼ · 1 stocks
The Kraft Heinz Company
KHC
▼ NegativeCapitalrelevance

Analysts set bearish price target implying 5.8% decline; shrinking unit sales, projected 2.2% revenue drop, and operating margin plunge of 25.1 percentage points.

Biotech & Genomic Medicine▲ · 1 stocks
Eli Lilly and Company
LLY
▲ PositiveCapitalrelevance

Consensus target suggests nearly flat return but strong fundamentals: 41.8% annual revenue growth, expanded operating margin, and share repurchases boosting EPS growth.

Industrials▼ · 1 stocks
Schneider National Inc
SNDR
▼ NegativeCapitalrelevance

Analysts set bearish price target implying 7.2% decline; unexciting sales growth, 14.9% annual EPS decline over five years, and shrinking returns on capital.

© 2026 MarketDXNews